MD-4251 |
MD-4251 : Degrader (PROTAC) of MDM2
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| MDM2 |
|
Degrader (PROTAC)
up to 30 nM
Selectivity
In Cell Selectivity Assessment
Potency Assay Off-Target:
MD-4251 was evaluated for GSPT1, IKZF1/3, and CK1α, a number of known neo-substrates for cereblon li ...
In Cell Selectivity Assessment
Potency Assay Off-Target:
Cellular degradation selectivity of MD-4251 was evaluated via an unbiased proteomics analysis. MD-42 ...
Potency Cellular
In Vitro
MDM2
Mode of Action: Degrader (PROTAC)
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1021/acs.jmedchem.5c00809
In Vivo Validations
Mouse
Dose: 1 mg/Kg
Route of delivery:
Intravenous
Plasma half life:
17.6 h
Systemic clearance:
0.576 mL/min/kg
Area Under the Curve::
28977 h*ng/min
Volume of Distribution at Steady-State:
0.858 L/Kg
DOI Reference: 10.1021/acs.jmedchem.5c00809
Dose: 3 mg/Kg
Route of delivery:
Oral
Plasma half life:
>24 h
Cmax:
1157 ng/mL
Tmax:
6.67 h
Area Under the Curve::
20658 h·ng/mL
Bioavailability:
38.8%
DOI Reference: 10.1021/acs.jmedchem.5c00809
Chemical Information
| Molecular Formula | C47H53Cl2FN8O4 |
| SMILEs | Cn1nc(C2CCC(=O)NC2=O)c2ccc(N3CCN(C[C@H]4CC[C@H](NC(=O)[C@@H]5NC6(CCCCC6)[C@@]6(C(=O)Nc7cc(Cl)ccc76)[C@H]5c5cccc(Cl)c5F)CC4)CC3)cc21 |
| InChI | InChI=1S/C47H53Cl2FN8O4/c1-56-37-25-30(13-14-31(37)41(55-56)33-15-17-38(59)53-43(33)60)58-22-20-57(21-23-58)26-27-8-11-29(12-9-27)51-44(61)42-39(32-6-5-7-35(49)40(32)50)47(46(54-42)18-3-2-4-19-46)34-16-10-28(48)24-36(34)52-45(47)62/h5-7,10,13-14,16,24-25,27,29,33,39,42,54H,2-4,8-9,11-12,15,17-23,26H2,1H3,(H,51,61)(H,52,62)(H,53,59,60)/t27-,29-,33?,39-,42+,47+/m0/s1 |
| Molecular weight | 882.36 Da |
| AlogP | 6.685000000000008 |
| HBond acceptors | 12 |
| HBond donors | 4 |
| Atoms | 115 |